Detalles de la búsqueda
1.
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study.
medRxiv
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38370787
2.
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.
Drug Saf
; 46(8): 797-807, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37328600
3.
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.
BMJ Med
; 2(1): e000651, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37829182
4.
Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs.
Front Pharmacol
; 13: 893484, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35873596
5.
Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.
Front Pharmacol
; 13: 837632, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35392566
6.
Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.
Front Pharmacol
; 13: 1088973, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36506524
7.
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis.
Front Pharmacol
; 12: 773875, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34899334
8.
Authors' Response to Huang et al.'s Comment on "Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance".
Drug Saf
; 47(4): 403-404, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38441750
Resultados
1 -
8
de 8
1
Próxima >
>>